20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Botanical formulations
#902METHOD FOR IMPROVING LANGUAGE SKILLS IN CHILDREN WITH SUSPECTED OR CONFIRMED CEREBRAL PALSY OR CHILDREN AT INCREASED RISK THEREOF
#903PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF
#904METHOD FOR REDUCING OR PREVENTING GLOBAL DEVELOPMENTAL DELAY IN CHILDREN
#905LIPOSOME COMPOSITION FOR RELIEVING SYMPTOMS OF PARKINSON'S DISEASE AND ALZHEIMER'S DISEASE
#906Use of isothiocyanate compounds
#907Compositions comprising rumenic acid-rich conjugated linoleic acid for brain health
#908Nutrition blend for health benefits in animals
#909Nutrition blend for health benefits in animals
#910Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
#911INHIBITION OF MIR-22 MIRNA BY APT-110
#912Lysosomal degradation of lipids and proteins and method of use thereof
#913FATTY ACID COMPOSITION AND PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
#914Lipid compositions containing bioactive fatty acids
#915Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin
#916METHOD AND APPARATUS FOR THE MANUFACTURE OF SOFTGELS
#917IMPROVEMENT IN MUSCLE FUNCTIONALITY OF ELDERLY MALES
#918Systems and methods for thrombosis prevention
#919NUTRITIONAL COMPOSITIONS AND THEIR USE
#920Factors for the production and accumulation of polyunsaturated fatty acids (PUFAs) derived from PUFA synthases
#921Lipid comprising long chain polyunsaturated fatty acids
#922Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
#923Compositions and methods for treating chronic inflammation and inflammatory diseases
#924Dietary nutrient compositions
#925Solid solution compositions and use in chronic inflammation
#926Cosmetic compositions and method of treating the skin
#927GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#928Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
#929Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material
#930SYNBIOTICS COMBINATION FOR BRAIN IMPROVEMENT
#931METHOD FOR TREATING BRAIN ATROPHY
#932OIL COMPOSITIONS AND METHODS OF MAKING
#933Methods of treating mixed dyslipidemia
#934COMPOSITION COMPRISING PROTECTIN DX AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR FATTY LIVER DISEASE
#935Solid solution compositions and use in chronic inflammation
#936Compositions and methods using a polyphenol for musculoskeletal health
#937Method for supporting memory function and/or cognitive function
#938Pomegranate oil for preventing and treating neurodegenerative diseases
#939Functional feed
#940Topical cyclosporine-containing formulations and uses thereof
#941COMPOSITION AND METHOD FOR TREATING MIGRAINES
#942PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME
#943COMPOSITIONS AND METHODS FOR PREVENTING, ALLEVIATING, AND TREATING NEUROLOGICAL INJURY FOLLOWING HEAD TRAUMA
#944Composition and Nutritional Supplement Made Therefrom
#945Methods reducing or preventing oxidation of high density lipoprotein (HDL)
#946ALLEVIATING OXIDATIVE STRESS DISORDERS WITH PUFA DERIVATIVES
#947NOVEL COATING SYSTEM (I)
#948IMPAIRED ENERGY PROCESSING DISORDERS AND MITOCHONDRIAL DEFICIENCY
#949TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS
#950Oxidative retinal diseases
#951Lipid scavenging in Ras cancers
#952NOVEL COATING SYSTEM (II)
#953BCMA monoclonal antibody-drug conjugate
#954Nutritional composition
#955METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#956Oral formulations of bipolar trans carotenoids
#957Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#958THERAPEUTIC AGENT FOR DYSLIPIDEMIA
#959DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM
#960Emulsified fatty acids
#961Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
#962Ingestible medical delivery devices
#963Lipid compositions with high DHA content
#964METHOD OF PRODUCING EGG YOLK BASED FUNCTIONAL FOOD PRODUCT AND PRODUCTS OBTAINABLE THEREBY
#965COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#966Composition for preventing or improving peripheral neuropathy
#967Solid solution compositions and use in chronic inflammation
#968DIETARY SUPPLEMENTS AND FORMULATIONS
#969DIETARY SUPPLEMENTS AND FORMULATIONS
#970Solid solution compositions and use in chronic inflammation
#971Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#972Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
#973Self-emulsifying composition of ω3 fatty acid
#974Topical pharmaceutical composition of acitretin
#975COMBINATION OF OILS
#976NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN
#977Nutritional composition and infant formula for promoting myelination of the brain
#978Nutritional composition and infant formula for promoting de novo myelination
#979NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN
#980NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN
#981NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN
#982Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position
#983Compositions and methods using a polyphenol for musculoskeletal health
#984Lipid formulations containing bioactive fatty acids
#985Composition for preventing and/or treating cardiovascular and cerebrovascular diseases
#986NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS TO PROMOTE MYELINATION IN THE BRAIN
#987NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF
#988PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#989Semifluorinated alkane compositions
#990Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
#991HALOGENATED ESTERS OF CYCLOPROPANATED UNSATURATED FATTY ACIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
#992Millicapsule formulations comprising polyunsaturated free fatty acids
#993Isotretinoin formulations and uses and methods thereof
#994BEADLETS COMPRISING CAROTENOIDS
#995Bioeffective krill oil compositions
#996Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
#997METHOD FOR IMPROVING WHITE MATTER INTEGRITY IN HYPERPHENYLALANINEMIA AND PHENYLKETONURIA PATIENTS
#998Compositions and methods for the treatment of cancer
#999TOPICAL ANALGESIC PAIN RELIEF FORMULATIONS, MANUFACTURE AND METHODS OF USE THEREOF
#1000Compositions for mitigating brain trauma and methods thereof
#1001Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
#1002INFANT FORMULA WITH MILK FAT FOR PROMOTING HEALTHY GROWTH
#1003PRODUCTION OF DHA AND OTHER LC PUFAS IN PLANTS
#1004Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#1005TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#1006Omega-3 compositions, dosage forms, and methods of use
#1007Nutritional Product for Decreasing Phenylalanine Levels in PKU Patients
#1008events LBFLFK and LBFDAU and methods for detection thereof
#1009Dietary supplements for treating ADHD and related disorders
#1010SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS
#1011Capsule with internal diaphragm and solid ingredients
#1012Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1013Modification of plant lipids containing PUFAs
#1014Stabilising fatty acid compositions
#1015COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS
#1016LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND A NON-FATTY ACID ANTI-INFLAMMATORY AGENT
#1017Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1018Composition containing norbixin for protecting cells of the retinal pigment epithelium
#1019Capsule with volume-adjustable internal diaphragm
#1020Stable pharmaceutical composition and methods of using same
#1021Fish egg extracts, omega-3 lipid-based compositions and uses thereof
#1022METHOD FOR IMPROVING EQUILIBRIOCEPTION IN HEALTHY INDIVIDUALS AND NUTRITIONAL COMPOSITION
#1023Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
#1024Methods, compositions, and devices for supplying dietary fatty acid needs
#1025ENTERAL FEEDING DEVICE
#1026Trans carotenoids, their synthesis, formulation and uses
#1027OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS
#1028All-natural enteric soft capsules
#1029Combination of creatine, an omega-3 fatty acid, and citicoline
#1030TREATMENT OF SKIN CONDITIONS
#1031Methods, compositions, and devices for supplying dietary fatty acid needs
#1032BIOEFFECTIVE KRILL OIL COMPOSITIONS
#1033Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
#1034A METHOD AND A DISPENSING ARRANGEMENT FOR TREATING A FLOW OF VAPORIZED LIQUID PROVIDED BY AN E-CIGARETTE AND AN E-CIGARETTE FOR THE ORAL INTAKE OF VAPORIZED LIQUID CONTAINING AN ADDITIONAL COMPOSITION
#1035Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#1036Reduced fat, shelf stable liquid nutritional composition
#1037Lipid formulations containing bioactive fatty acids
#1038Glycine for use in tolerance induction in allergic patients
#1039Phospholipid preparations for the improvement of sleep
#1040Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
#1041FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF
#1042Methods and products to provide oral nutritional care to subjects with dementia
#1043NEUROTRANSMITTER AND BRAIN MODULATING ORAL DELIVERY SYSTEM FOR ENHANCEMENT OF COGNITIVE FUNCTIONS AND ENERGY
#1044Method of using a composition for enhancing newborn infant cognitive, brain and/or CNS development
#1045Methods for the production of diatom biomass
#1046Use of H3K9me3 modulation for enhancing cognitive function
#1047VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS
#1048Treatment and prevention of liver disease associated with parenteral nutrition (PN)
#1049Omega-3 fatty acid articles of manufacture, and methods and apparatus for making same
#1050PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#1051Methods for treating dry eye
#1052Omega-3 and/or omega-6 fatty acid(s) in impaired sphingolipid metabolism
#1053Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections
#1054Stable fat-soluble active ingredient composition, microcapsule and process of preparation and use thereof
#1055Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
#1056Compositions and methods relating to salts of specialized pro-resolving mediators
#1057Compositions for Mitigating Head Trauma
#1058TRANSPAPILLARY METHODS AND COMPOSITIONS FOR TREATING BREAST DISORDERS
#1059Methods of assessing future memory loss by measuring polyunsaturated fatty acids
#1060Free polyunsaturated fatty acid-containing composition and manufacturing method therefor
#1061Prevention of symptoms related to fluctuating female hormone levels
#1062Bioeffective krill oil compositions
#1063Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
#1064Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same
#1065METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#1066Combination methods and compositions including sleep therapeutics for treating mood
#1067Compositions and methods for diagnosis and treatment of anemia
#1068Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
#1069Pet food compositions
#1070NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#1071Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
#1072Enteric soft capsules comprising polyunsaturated fatty acids
#1073Enhanced bioavailability of polyunsaturated fatty acids
#1074Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1075Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species
#1076Emulsified fatty acids
#1077NUTRITIONAL COMPOSITIONS CONTAINING INOSITOL AND USES THEREOF
#1078COMPOSITIONS AND METHODS THAT MODULATE BACTERIA IN A COMPANION ANIMAL
#1079Compositions and methods that modulate cholesterol in a companion animal
#1080Very long chain polyunsaturated fatty acids from natural oils
#1081Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1082NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#1083Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1084NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#1085ESSENTIAL NUTRIENTS AND RELATED METHODS
#1086Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction
#1087Anti-inflammatory omega-3 synergistic combinations
#1088Powder composition containing oily substance
#1089Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease
#1090Compositions for Mitigating Head Trauma
#1091Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1092Skin barrier repair and maintenance composition
#1093LIPID COMPOSITIONS FOR IMPROVING SLEEP
#1094NUTRITIONAL COMPOSITIONS PROVIDING DIETARY MANAGEMENT OF COLIC
#1095NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#1096Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1097CYP450 lipid metabolites reduce inflammation and angiogenesis
#1098Composition of nigella sativaseeds to treat anxiety, stress and sleep disorders with significant memory enhancement properties and a process for producing the same
#1099THERAPY FOR LEUKEMIA
#1100Pharmaceutically acceptable salts of fatty acids
#1101METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS
#1102Methods of reversing autonomic nervous system damage
#1103Topical compositions comprising polyunsaturated fatty acids
#1104COMPOSITION OF BIOACTIVE LIPIDS AND METHODS OF USE THEREOF
#1105BIOCONJUGATE MOLECULES WITH BIOLOGICAL AND TECHNO-FUNCTIONAL ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
#1106Compositions and methods relating to salts of specialized pro-resolving mediators
#1107Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
#1108COMPOSITION FOR REDUCING OR SUPPRESSING INCREASE IN NEUTRAL FAT LEVEL CONTAINING N-3 UNSATURATED FATTY ACID, AND USE OF N-3 UNSATURATED FATTY ACID IN PRODUCTION OF SAME COMPOSITION
#1109USE OF THIA OXO COMPOUNDS FOR LOWERING APO C3
#1110COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
#1111Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#1112Prevention of psychotic disorders and/or treatment of psychotic symptoms
#1113PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#1114Compositions comprising 15-HEPE and methods of using the same
#1115Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
#1116PRODUCTION OF NITRO-FATTY ACIDS AND NITRO-HYDROCARBONS BY AMMONIA OXIDIZING BACTERIA
#1117IDENTIFICATION AND USE OF VERY LONG CHAIN DICARBOXYLIC ACIDS FOR DISEASE DIAGNOSIS, CHEMOPREVENTION, AND TREATMENT
#1118COMPOSITIONS AND METHODS FOR COGNITIVE HEALTH AND MEMORY
#1119Infant nutritional product with RRR alpha-tocopherol
#1120METHODS OF TREATING PEDIATRIC METABOLIC SYNDROME
#1121Use of derivatives of polyunsaturated fatty acids as medicaments
#1122COMPOSITIONS FOR MITIGATING HEAD TRAUMA
#1123COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF
#1124Methods for Stabilizing Atherosclerotic Plaques Using Lipoxins, Resolvins, and Analogs Thereof
#1125NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF
#1126Methods of treating or preventing prostate cancer
#1127Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#1128Fast acting joint relief formulations
#1129NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#1130NUTRITIONAL COMPOSITIONS AND ASSOCIATED METHODS
#1131System for preparing medicinal beverages using cartridge-type beverage brewers
#1132CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#1133Method for manufacturing long chain polyunsaturated fatty acid-containing fat
#1134Purified compositions of polyunsaturated fatty acids, their preparation method and their use
#1135Concentrated Solution of 17-Hydroxydocosahexaenoic Acid
#1136Solid solution compositions and use in chronic inflammation
#1137Solid solution compositions and use in chronic inflammation
#1138COMPOSITIONS AND METHODS OF TREATMENT OF BREAST DISORDERS AND ESTROGEN-RELATED DISORDERS
#1139Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#1140Eye health composition
#1141Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject
#1142Methods of reducing triglycerides and LDL-C
#1143Solid solution compositions and use in chronic inflammation
#1144Compositions containing non-polar compounds
#1145Dihomo-γ-linolenic acid-containing microbial oil and dihomo-γ-linolenic acid-containing microbial biomass
#1146Pharmaceutical compositions comprising DGLA and use of same
#1147Natural lipids containing non-oxidizable fatty acids
#1148FATTY ACID NIACIN CONJUGATES AND THEIR USES
#1149METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS
#1150COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR
#1151LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS
#1152Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines
#1153All-natural enteric soft capsules
#1154Method for increasing performance of offspring
#1155Kits and methods for nutrition supplementation
#1156COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME
#1157Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors
#1158TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES
#1159Therapeutic target for the treatment of cancers and related therapies and methods
#1160Feed ingredients comprising lysed microbial cells
#1161Glycerophospholipids for the improvement of cognitive functions
#1162Self-emulsifying composition of omega-3 fatty acid
#1163Nutritional composition useful in the treatment of IBD patients
#1164Use Of Xanthophyll Carotenoids To Improve Visual Performance And Neural Efficiency
#1165INFANT FORMULA COMPRISING HUMAN MILK OLIGOSACCHARIDES, POLYUNSATURATED FATTY ACIDS, NUCLEOTIDES, AND LUTEIN
#1166Non-winterized, standardized marine source oil products and methods of making thereof
#1167Compositions containing as the active ingredient components from seed
#1168LONG-CHAIN POLYUNSATURATED FATTY-ACID-CONTAINING FAT AND FOOD CONTAINING SAME
#1169Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
#1170DISRUPTION OF THE INTERACTION BETWEEN AMYLOID BETA PEPTIDE AND DIETARY LIPIDS
#1171Feeding Algae to Cattle at Low Doses to Produce High Omega 3 Levels in Beef
#117214-hydroxy-docosahexaenoic acid compounds
#1173Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#1174METHODS AND COMPOSITIONS FOR MODULATING SEROTONIN LEVELS
#1175COMPOSITIONS CONTAINING OMEGA-3 OIL AND USES THEREOF
#1176SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
#1177Methods, compositions, and devices for supplying dietary fatty acid needs
#1178Materials and methods for increasing the tocopherol content in seed oil
#1179Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract
#1180Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
#1181Method and apparatus for the manufacture of softgels
#1182PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF
#1183PRODUCTION OF ULTRAPURE EPA AND POLAR LIPIDS FROM LARGELY HETEROTROPHIC CULTURE
#1184Prophylaxis and treatment of preterm birth associated bronchopulmonary dysplasia (BPD)
#118514-hydroxy-docosahexaenoic acid compounds
#1186Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
#1187Compounds and Methods for Modulating Vascular Injury
#1188Lipid comprising docosapentaenoic acid
#1189Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed
#1190Dietary emulsion formulations and methods for using the same
#1191Eicosapentaenoic acid (EPA) formulations
#1192Method for producing biomass which has a high exopolysaccharide content
#1193Probiotic Stabilization
#1194COMBINATIONAL COMPOSITIONS AND METHODS OF USE THEREOF
#1195Method of manufacturing enteric seamless soft capsule
#119614-hydroxy-docosahexaenoic acid compounds
#1197Fish oil topical composition
#1198THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD
#1199Stealth, targeted nanoparticles (STN) for oral drug delivery
#1200CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN